REQUEST A DEMO
Total
USD $0.00
Search more companies

Paulipharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Paulipharma Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Paulipharma Kft. is based in Hungary. The head office is in Kecskemet. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on May 20, 2008. Paulipharma Kft. currently employs 7 (2024) people. There was a net sales revenue increase of 16.33% reported in Paulipharma Kft.’s latest financial highlights for 2024. Its total assets grew by 13.66% over the same period. The net profit margin of Paulipharma Kft. increased by 1.78% in 2024.

Headquarters
Jokai utca 27.
Kecskemet; Bacs-Kiskun; Postal Code: 6000

Contact Details: Purchase the Paulipharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Paulipharma Kft. report to view the information.
Registered Capital:
Purchase the Paulipharma Kft. report to view the information.
Financial Auditors:
Purchase the Paulipharma Kft. report to view the information.
Incorporation Date:
May 20, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Paulipharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
16.33%
Total operating revenue
17.01%
Operating profit (EBIT)
118.56%
EBITDA
106.72%
Net Profit (Loss) for the Period
240.09%
Total Assets
13.66%
Total Equity
22.61%
Operating Profit Margin (ROS)
1.64%
Net Profit Margin
1.78%
Return on Equity (ROE)
11.79%
Quick Ratio
0.12%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?